Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology | Gastroenterology

Colon Cancer

Arizona

Peoria : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

California

Duarte : City of Hope

CTSU/NCCTG:N0147 A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or w/o Cetuximab (C225) After Curative Resection for Patients with Stage III Colon Cancer

Duarte : City of Hope

Detection of Carcinomas Using 123Iodine-Labeled T84.66 Diabody Antibody Fragment to Carcinoembryonic Antigen (CEA)

Duarte : City of Hope

Evaluation of Colon/Rectal Cancer Patterns and Outcomes of Care

Duarte : City of Hope

Measurement of Serum Circulating Tumor Cells in Pancreatic , Liver, Gastric and Gastrointestinal Neuroendocrine Tumors for Predicting Prognosis and Evaluating Therapeutic Response

Duarte : City of Hope

NSABP Protocol C-10: A Phase II Trial of 5-Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) Chemotherapy Plus Bevacizumab for Patients with Unresectable Stage IV Colon Cancer and a Synchronous Asymptomatic Primary Tumor

Duarte : City of Hope

Role of Glutathione Peroxidase and Helicobacter Spp. in Inflammatory Bowel Disease and Colonic Cancer

Duarte : City of Hope

Understanding Comorbidity in Patients with Colon Cancer

Los Angeles : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Colorado

Denver : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Florida

Hialeah : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Illinois

Chicago : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Chicago : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Elgin : Sherman Health Systems

Randomized phase III study for stage II colon cancer at high risk for recurrence Comparing 5-FU, leucovorin and Oxalplatin versus 5-FU, leucovorin, oxaliplatin and bevacizumab to determine prospectively the prognostic value of molecular markers

Hines : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Indiana

Beech Grove : St. Francis Hospital and Health Centers

A Randomized, Multicenter, Phase 2 Study to Compare the Efficacy of Panitumumab in Combination With mFOLFOX6 to the Efficacy of Bevacizumab in Combination With mFOLFOX6 in Patients With Previously Untreated, KRAS Wild-Type, Unresectable, Metastatic Colorectal Cancer

Kentucky

Lexington : University of Kentucky Chandler Medical Center

Cancer: Research Study for Colon Cancer Patients and Patients with First Degree Relatives with Colon Cancer

Massachusetts

Boston : Massachusetts General Hospital

The Staging of Gastrointestinal Malignancies by Endosonography: A New Echoendoscope

Missouri

Saint Louis : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

New Jersey

Newark : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

New York

Bronx : Biomedical Research Alliance of New York

Colon or rectal cancer - Adults

East Syracuse : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Rochester : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Rhode Island

Providence : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Texas

Houston : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Houston : S. R. Burzynski Clinic

Phase II Study Of Antineoplaston A10 And AS2-1 Capsules In Patients With Adenocarcinoma Of The Colon

Houston : S. R. Burzynski Clinic

Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Adenocarcinoma Of The Colon

Virginia

Charlottesville : University of Virginia

Evaluation of the Immunogenicity of Vaccination with Her-2/neu and CEA derived Synthetic Peptides with GM-CSF-in-Adjuvant, in Patients with Resected Stage IIB or III Abdominal Colon Cancer HIC# 9976

Charlottesville : University of Virginia New!

Undergoing a Colonoscopy?

Washington

Seattle : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Australia

South Granville : Merck Sharp & Dohme (Australia) Pty Ltd.

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals